AI assistant
Sending…
FIBROGEN INC — Director's Dealing 2015
Nov 11, 2015
34576_dirs_2015-11-10_c4267c1e-aa65-47d1-ba86-dd5855d69b48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-11-09
Reporting Person: Yu K Peony (VP, Clinical Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-09 | Common Stock | S | 2500 | $25.00 | Disposed | 190404 | Direct |
| 2015-11-10 | Common Stock | S | 2500 | $26.23 | Disposed | 187904 | Direct |
Footnotes
F1: Shares sold pursuant to a 10b5-1 plan.
More from FIBROGEN INC
Regulatory Filings
2026
Apr 9
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Regulatory Filings
2026
Jan 7
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Dec 9
Director's Dealing
2025
Nov 17
Major Shareholding Notification
2025
Nov 15
Interim / Quarterly Report
2025
Nov 10
Regulatory Filings
2025
Nov 10